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SalinomycinThe molecular mechanism of Salinomycin's toxicity is not fully understood. Various studies reported that
Ca2+, cytochrome c, and caspase activation play a role in Salinomycin-induced cytotoxicity. Furthermore,
Salinomycin may target Wnt/β-catenin signaling pathway to promote differentiation and thus elimination
of cancer stem cells. In this study, we show a massive autophagic response to Salinomycin (substantially
stronger than to commonly used autophagic inducer Rapamycin) in prostrate-, breast cancer cells, and to
lesser degree in human normal dermal ﬁbroblasts. Interestingly, autophagy induced by Salinomycin is a
cell protective mechanism in all tested cancer cell lines. Furthermore, Salinomycin induces mitophagy,
mitoptosis and increased mitochondrial membrane potential (ΔΨ) in a subpopulation of cells. Salinomycin
strongly, and in time-dependent manner decreases cellular ATP level. Contrastingly, human normal dermal
ﬁbroblasts treated with Salinomycin show some initial decrease in mitochondrial mass, however they are
largely resistant to Salinomycin-triggered ATP-depletion. Our data provide new insight into the molecular
mechanism of preferential toxicity of Salinomycin towards cancer cells, and suggest possible clinical applica-
tion of Salinomycin in combination with autophagy inhibitors (i.e. clinically-used Chloroquine). Furthermore,
we discuss preferential Salinomycins toxicity in the context of Warburg effect.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY license.1. Introduction
Salinomycin was originally used as an anticoccidial drug in poultry,
and for efﬁcient nutrient absorption in piggery. Its preferential toxicity, Beclin1; HMGB1, high mobil-
d protein 1 light chain 3; Mfn,
mTOR, mammalian target of
receptor gamma coactivator
ion pore
ntalMedicine (IKE), Integrative
ity, Cell Biology Building, Level
B.V. Open access under CC BY license.towards cancer-stem cells was described by Gupta and colleagues in
the end of the last decade [1]. Salinomycin's toxicity towards cancer
stem cells was further supported by recent studies in gastrointestinal
sarcoma, osteosarcoma, and colorectal and breast cancers [2–4]. Even
though the cell death mechanisms induced by Salinomycin still remain
elusive, a recent study by Lu et al. shows that Salinomycin targets cancer
stem cells by blocking Wnt/β-catenin pathway, which is critical for
stem cell self renewal [5]. While Salinomycin is relatively non-toxic to
primary cells, Boehmerle et al., show that Salinomycin induced cell
death is through conventional caspase mediated apoptotic pathways
[6]. Our own experiments (please see below) show that Salinomycin
preferentially kills cancer cells.
Cellular house-keeping, homeostatic mechanism autophagy includes
macroautophagy (bulk degradation including cellular organelles),
microautophagy (uptake of cytoplasm for degradation) and chaperone
mediated autophagy (CMA) (protein speciﬁc degradation) [7–9]. In the
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PI3K/Akt pathway through activation of mTOR (mammalian target of
rapamycin) [10,11]. However, under nutrient deprivation or stress,
inhibition of mTOR initiates phagophore formation through nucleation
complex of autophagy involving ULK1/2, Beclin1 and other molecules.
Several Autophagy Related Gene (ATG) family members ATG3, ATG5,
ATG7, ATG12 etc., carry on further elongation of phagophore to form
autophagosome [10,12]. Autophagosomes carry dysfunctional cellular
organelles (mitochondria, peroxisomes, ribosomes etc.) for degradation
by fusing with lysosomes. More recent studies show alternative
autophagic pathway independent of ULK, ATG5 and ATG7 mediated
mechanism-requiring Beclin1 [10,13,14]. Organelle speciﬁc autophagy
has been reported for mitochondria (mitophagy), endoplasmic reticu-
lum (ER-phagy), ribosomes (Ribophagy) etc., as amechanism to remove
the dysfunctional organelles, or as a response to stress triggered by
cytoplasmic overload with damaged organelles[15].
Mitochondria, commonly called the powerhouses of the cell, form a
dynamic interconnected network of tubular structures that are engaged
in ﬁssion and fusion processes [16]. Mitochondrialﬁssion ismediated by
localization of Drp1 on themitochondrial site of divisionwhereas fusion
is mediated bymitofusin proteins (mitofusins 1 and 2) alongwith OPA1
[17]. Lack of both mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2) leads to
impaired mitochondrial fusion but both of them can compensate each
others loss [18–21]. Under the event of stress or any event leading to
dysfunction of normal mitochondria, the organelle undergoes an asym-
metric, protective ﬁssion, that aims to spare at least part of stressed
mitochondria, by splitting the organelle into a normally-functioning
part, and a dysfunctional one. The process allows for subsequent degra-
dation of dysfunctional mitochondria created in such a way, while
sparing the functional ones.
Rehman and colleagues have recently described that cancer cells
often havemuch smaller, fragmentedmitochondria as compared to nor-
mal cells [22]. In the same study they show that cancer cells express an
increased level of Drp1 and decreased level of Mfn protein, promoting
a constant mitochondrial ﬁssion with impaired fusion, resulting in a
smaller fragmented mitochondria in cancer cells [22]. Modiﬁcation of
the level of expression of Drp1 orMfn in cancer cells decreased their pro-
liferation, thus indicating that targeting of molecules regulating mito-
chondrial dynamics and function is a potentially novel target for cancer
therapy [22].
The maintenance of mitochondrial inner membrane potential is
crucial for both ATP production and functions related to the induction
of apoptosis. Opening of the outer mitochondrial membrane perme-
ability transition pore (PTP) leads to cytochrome c release from the
inter-membrane space of the mitochondria along with depolarization
of the inner membrane and thus subsequently inhibiting the ATP pro-
duction [23,24]. However it is argued that the mitochondrial mem-
brane potential has to be maintained for the release of cytochrome c
and further apoptotic signaling cascade to occur [25,26]. Others pro-
pose the mitochondrial hyperpolarization and thus mitochondrial
condensation during apoptosis induction [27,28]. Irrespective of the
mechanism, mitochondrial release of cytochrome c into the cytosol
is the trigger and component for the formation of apoptosome that
leads to the activation of caspase cascade. Along with apoptosis, au-
tophagy may under certain circumstances act as an alternative cell
death mechanism [29].
In this study, we have been investigating the mechanism of
Salinomycin anticancer toxicity. Here we show that Salinomycin in-
duces autophagy, andmitophagy. The autophagic response is a cell pro-
tective mechanism in prostate and breast cancer cells. We also report
the critical role of Salinomycin in increasing the mitochondrial mem-
brane potential (hyperpolarization) and activation of a programmed
cell death through the differential activation of caspases among cancer
cells. Our experimental data indicate that Salinomycin-triggered deple-
tion of cellular ATP, in cancer cells but not in primary cells, contributes
towards Salinomycin's preferential anticancer toxicity.2. Materials and methods
2.1. Cells and cell culture
Prostrate cancer cell line (PC3), breast cancer cell lines (SKBR3 and
MDAMB468) and murine embryonic ﬁbroblast (MEF) cells, all available
at our lab's cell bank, were cultured in RPMI media with 10% FBS and
1% penicillin–streptomycin antibiotics. MEF-ATG5−/− described previ-
ously [30], and human normal dermal ﬁbroblasts, provided by Dr. Kratz
[31], were cultured in DMEM media with 10% FBS and 1% penicillin. All
the cell lines were maintained at a conﬂuence of ~70%.
2.2. Materials and reagents
Salinomycin, Rapamycin, Baﬁlomycin, Chloroquine, Pepstatin and
ED-64were obtained from Sigma-Aldrich and dissolved in their respec-
tive buffers as per required concentrations. Rabbit-anti-LC3b, rabbit-
anti-HMGB1, and murine anti-actin were also from Sigma-Aldrich
whereas rabbit-anti-ATG5 was obtained from Cellular Signaling Inc.
The secondary antibodies anti-rabbit HRP-conjugate and anti-murine
HRP-conjugates were obtained from Sigma-Aldrich and anti-rabbit-
Alexaﬂuor488 and -594 were purchased from Life Technologies Ltd.
MitoTracker Red CMXRos, LysoTracker Red DND-99, and MitoTracker
Green FM were also purchased from Life Technologies Ltd.
2.3. Transmission electron microscopy (TEM)
Cells were initially ﬁxed with 2% Glutaraldehyde in 0.1 M Sodium –
cacodylate-HCl buffer with 0.1 M sucrose, (pH 7.4) for 2 h at 4 °C and
post ﬁxed with 1% OsO4 in 0.15 M Sodium – cacodylate-HCl buffer for
1 h. Cells were dehydrated in ethanol gradually and embedded in Epon
812. Ultrathin sectionswere cut on a Reichert Ultracut SUltramicrotome,
mounted on copper grids, air-dried, and further stained with uranyl
acetate and lead citrate. Sections were examined and photographed
with JEOL JEM 1230 electron microscope at 100 kV [29].
2.4. MTT assay
100 μl of cells diluted at a concentration of 105 cells/ml were plated
to eachwell of a 96well plate and incubated in a humidiﬁed CO2 cham-
ber for 24 h. The next day, cells were treated as per respective experi-
mental conditions (please see Results section and ﬁgure legends for
details). After indicated time periods of treatments, 10 μl of 5 mg/ml
3-(4,5-dimethyl-2-thiazolyl) 2,5-diphenyl-2H tetrazolium bromide
(MTT) solution (Sigma-Aldrich) was added to each well, incubated for
3 h and centrifuged at 90 g for 10 min. The supernatant was re-
moved and the formed farmazan-crystals were dissolved in a solu-
tion containing equal volumes of DMSO:ethanol. The readings were
taken at both 570 and 630 nm.
2.5. Po-Pro and 7-AAD cell death assay
Cells treatedwith orwithout Salinomycin atmentioned concentra-
tions for the respective time periodswere trypsinized and collected by
centrifugation at 400 g for 5 min. The pelleted cells were resuspended
in PBS and treated with Po-Pro and 7-AAD dyes (Life Technologies
Ltd.) for 30 min as per manufacturer's instructions and analyzed
using ﬂow cytometer (Gallios, Beckman Coulter Inc.). Flow cytometry
results were analyzed using Kaluza analysis software (Beckman Coul-
ter Inc.).
2.6. Western blotting
Cells were lysed using RIPA buffer with Protease inhibitors (cOm-
plete Roche) and centrifuged to remove the debris. Cell lysates were
loaded into a 12% polyacrylamide gel and ran at 100 V for 3 h and then
2059J.R. Jangamreddy et al. / Biochimica et Biophysica Acta 1833 (2013) 2057–2069transferred on to a PVDFmembrane for 1 h at 100 V. Themembranewas
blocked with 5%milk protein and treated with primary antibodies over-
night. The membrane is washed with 3× TBST and treated with respec-
tive secondary antibody for 1 h. The membrane is further washed with
3× TBST before developing using Amersham ECL plus Western blotting
developing kit (GE Technologies). To analyzeHMGB1 release the cellular
supernatant was collected and an equal amount of the supernatant wasFig. 1. Salinomycin treatment triggers autophagic response: (A) phase-contrast images show i
blots show increased expression of LC3II upon treatment with mentioned concentrations of Sa
signal and LysoTracker representing autophagosome and lysosomes respectivelywas observed
of experiment depicted on “C”: (D) 10 μM Salinomycin treatment increased number of cells sho
trols, (E) number of LysoTracker Red counts per cell, and (F) number of LC3 signals per cell reloaded into a 15% gel and Western blotting was conducted as described
above [32].
2.7. Immunocytochemistry
Cells plated on cover-slips in a 12-well plate were washed with PBS
after their respective treatment and ﬁxed using 4% paraformaldehydencreased vacuolization in cancer cells treated with 10 μM Salinomycin (Sal). (B) Western
linomycin for 24 and 48 h in PC3, SKBR3 and MDAMB468 cells. (C) Colocalization of LC3
using immuno-cytochemistry in primary and cancer cells. (D, E, F) Quantitative evaluation
wing higher than the threshold level of LC3 ﬂuorescence compared to the respective con-
lative to their controls. *Represents statistically signiﬁcant difference (P b 0.05).
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then placed in incubation buffer (0.1% saponin and 5% FBS in PBS) for
20 min at room temperature and then treated with primary antibody
(overnight at 4 °C) and respective secondary antibody with conjugated
ﬂuorophore (1 h at room temp.) intervened by 3× washing with incu-
bation buffer. The cells were washed and then mounted on a slide with
a mounting medium containing DAPI. Images were taken using Laser
Scanning Confocal Microscope (Zeiss).2.8. LC3 staining, LysoTracker count and mitochondrial count and size
Immunoﬂuorescent images of the cells treated with and without
Salinomycin and stained for LC3, LysoTracker, and MitoTracker
probes as per the manufacturer's protocol were analyzed by ImageJ
software subtracting the background, using threshold and analyzing
particle modules as described in a previous study [22]. A total of 30
cells from each experiment are analyzed for LC3 positive cell count
and a total of 10 cells were counted for the number of LC3 ﬂuorescent
dots and LysoTracker count. Mitochondrial size and count are ana-
lyzed using images taken at 3 random locations in each of the control
and Salinomycin treated samples. To further determine the inﬂuenceFig. 2. Salinomycin increases LC3II ﬂux upon inhibition of autophagy: (A)Western blottingwas
or absence of the autophagic inhibitor Chloroquine (Cq). Rapamycin (Rap), a well known aut
Salinomycin induces a stronger autophagic response as compared to Rapamycin. Salinomycin t
trol non-treated cells. (B) TEM images of SKBR3 cells treated with or without Salinomycin for
along with lysosomes and autophagosomes. Individual portraits of phagosomes and lysosome
lysosome formation and matured autophagolysosome.of autophagy on mitochondrial number the cells are selected based
on LC3 positivity as mentioned above.2.9. Mitochondrial membrane potential and mass measurement
Mitochondrial activity was measured with JC1 assay kit
(Sigma-Aldrich). 200× JC1 stock solution was diluted with distilled
water and 5× JC1 staining buffer as per the requirements to make 1×
JC1 solution and is added to the cells either in suspension (for ﬂow
cytometry) or attached to the plate (ﬂuorimetry) and incubated for
20 min at a 37 °C incubator. The cells were washed 2× with respective
media andﬂuorescencewasmeasured using a ﬂow cytometer using FL1
and FL2 channels (Gallios, Beckman Coulter Inc.) or ﬂuorescence plate
reader (Victor3V, PerkinElmer) and images were taken using a confocal
microscope (Zeiss). To further support the JC1 assay the same analysis
using ﬂow cytometry was performed with MitoTracker Green FM
(localized to mitochondrial membrane and thus determine mito-
chondrial mass) and MitoTracker Red CMXRos that localizes to the
matrix of the functional mitochondria with intact mitochondrial
membrane potential (indicates mitochondrial function) as men-
tioned previously.used to observe comparative expression of LC3II at different time intervals in the presence
ophagy inducer was used as a positive control for autophagy induction. Please note that
reatment of cell pretreatedwith Cq shows upregulated LC3II expression compared to con-
24 h. Salinomycin treated cells show an increased number of autophagolysosome formed
s were represented in the subpanel along with the images showing autophagosome and
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Fig. 3. Salinomycin induced autophagy promotes cancer cell survival: (A) inhibition of
autophagy by Chloroquine increased cancer cell death triggered by Salinomycin. The
effects on human normal dermal ﬁbroblasts were inconclusive due to a marked toxicity
of Chloroquine alone. (B) MEF cells lacking ATG5 showed signiﬁcant increase in cell
death compared to the respective controls at 24 h and 48 h. The Western blot shows
ATG5 level in the respective cells lines (cell line quality controls). *Represents statistically
signiﬁcant difference (P b 0.05).
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Cells treated with Salinomycin for the respective time periods were
washed with ice-cold PBS and treated with 100 μl of ATP releasing
agent (Sigma-Aldrich) for 5 min and 50 μl of the extract was added
into a light protected 96-well plate that was preloaded with 100 μl of
ATP assay mix solution (Sigma-Aldrich) and incubated for 3 min at
room temp. Immediately the luminescence was measured using lumi-
nescence plate reader (Victor3V, PerkinElmer).
2.11. Caspase activity assays
Caspase-3 activity and mitochondrial function were assessed using
NucView 488 and MitoView 633 (Biotium). Samples were prepared
similarly as Po-Pro assay as described above and treated with NucView
488 and MitoView 633 and kept on ice for 1 h before analyzing with
ﬂow cytometer (Gallios). Caspase-8 and -9 were analyzed using Green
FLICA andRed FLICA caspase assay kits respectively from ImmunoChem-
istry Technologies. The cells were incubated at 37 °C for 1 h before tak-
ing the ﬂuorescence, which was measured in FL1 and FL4 using Gallios
ﬂow cytometer (Beckman Coulter Inc.).
2.12. Statistics
All the statistics (one way ANOVA) were conducted using Prism
(version 6.0b) software and SPSS (IBM version 20) software. A P value
of less than 0.05 is considered statistically signiﬁcant unless mentioned
otherwise.
3. Results
3.1. Salinomycin induces autophagy
Initial observations of 10 μM Salinomycin treated cells indicate a
profound increase in vacuolization in breast cancer SKBR3 and
MDAMB468 cell lines, and to lesser degree in prostate cancer PC3
cells, upon 24 h treatment (Fig. 1A). The vacuolization is much less
pronounced in human normal dermal ﬁbroblasts. To investigate possi-
ble autophagosome formation levels of autophagic marker LC3II were
monitored in SKBR3, MDAMB468 and PC3 cells. As shown in Fig. 1B,
Salinomycin treated cells have an increased level of LC3I lipidation
and LC3II formation with different concentrations of Salinomycin
(1 μM, 2.5 μM and 10 μM) at 24 and 48 h. Autophagy was also con-
ﬁrmed using immuno-cytochemistry (Fig. 1C, D and Supplementary
Fig. 1) where 10 μM Salinomycin treated cells show an increase in the
number of LC3 positive cells, number of LC3ﬂuorescent signals (ﬂuores-
cent dots) per cell and the number of active lysosomes (using
LysoTracker) per cell (Fig. 1D). Fig. 1C also shows a localization of active
lysosomes (LysoTracker Red) and LC3 signal (green ﬂuorescent dots) in
the near vicinity (or colocalization) thus providing a strong evidence for
an active autophagic mechanism. The relative number of lysosome in-
crease (LysoTracker Red counts) per cell, is shown in Fig. 1E, whereas
the relative number increase of LC3 signals per cell (increase in
autophagosome formation relative to their controls), is shown in Fig. 1F.
To further support the increase in active autophagy in Salinomycin-
treated cells, LC3II-ﬂuxwasmonitored at different time periods in pros-
tate and breast cancer cell lines along with autophagy inhibitor. As pre-
dicted, an increase in LC3II accumulation was observed in Salinomycin
treated cells that are pretreated for 1 h with autophagy inhibitor
20 μMChloroquine (Fig. 2A, and Supplementary Fig. 2A). Similar obser-
vations were made using other autophagic inhibitors (Baﬁlomycin and
pepstatin-ED64 mix) (Supplementary data Fig. 2B). Further validation
of Salinomycin induced autophagic process was done by transmission
electronmicroscopy (Fig. 2B and Supplementary Fig. 3). Salinomycin in-
duces strong vacuolization and autophagosome formation. In the inset(bottom row) the representative images of lysosomes, autophagosomes
and complete autophagolysosomes are indicated.
3.2. Salinomycin triggered autophagy counteracts cell death in cancer cells
Since autophagymay promote either cell survival or cell death, we
tested by an MTT assay if autophagy inhibition by Chloroquine poten-
tiates, or inhibits Salinomycin's toxicity. Surprisingly, inhibition of
autophagy with Chloroquine (20 μM, Cq) in Salinomycin (10 μM,
Sal) treated cancer cells increased cell death in tested breast- and
prostate cancer cell lines, however, in human normal dermal ﬁbro-
blasts autophagy inhibition actually increased survival (Fig. 3A). As
shown in Fig. 3B, immortalized murine embryonic ﬁbroblasts deﬁ-
cient in ATG5 (ATG5-KO), a crucial gene involved in autophagosome
elongation, also show an increased cell death upon treatment with
Salinomycin, as compared to the respective control wild-type ﬁbro-
blasts (Fig. 3B).
3.3. Salinomycin treatment increases mitochondrial mass, and net
mitochondrial membrane depolarization in cancer cells but not in
primary cells, implications for cellular ATP-level
Our transmission electronmicroscopy data shown in Fig. 2B indicates
that some Salinomycin triggered autophagosomes contained damaged
2062 J.R. Jangamreddy et al. / Biochimica et Biophysica Acta 1833 (2013) 2057–2069mitochondria. Thus, in order to assess the function of mitochondria and
its role in Salinomycin induced cell death JC1 assay was used to analyze
mitochondrialmembrane potential andmitochondrialmass as described
previously [33]. Using JC1 assay we can assess the net mitochondrialA
B
C
Fig. 4. Net mitochondrial depolarization observed among cells treated with Salinomycin is
subset of cells: (A) Confocal images show increase of green ﬂuorescent signal upon Salino
primary ﬁbroblasts. (B) Change in JC1 green and red ﬂuorescence in cells treated with Sal
MDAMB468) show a major increase in the number of cells with increased green ﬂuorescenc
were used to display both parameters. Compensation was done using Kaluza software (Beck
from ﬂow cytometry. Cancer cells treated with Salinomycin show increased JC1 ratio comp
mitochondrial mass) and JC1 red ﬂuorescence (indicating mitochondrial membrane poten
MDAMB468 cells show an increase in both green and red ﬂuorescence at 24 h and 48 h ex
green ﬂuorescence. (E) Human normal dermal ﬁbroblasts showing a decrease in JC1 ratio at
sion of MFN2 and increases the expression of DRP1, in SKBR3 cells. *Represents statisticallymass, represented by green signal, and intact mitochondrial potential
represented by the red signal. As shown in Fig. 4AB, unlike human nor-
mal dermal ﬁbroblasts, cancer cells treated with Salinomycin respond
with the increase of mitochondrial mass (increased green ﬂuorescence).due to the increased mitochondrial mass; Salinomycin induces hyperpolarization in a
mycin treatment compared to controls, in cancer cell lines but in lesser extent among
inomycin for 24 h was detected by ﬂow cytometer. Cancer cell lines (PC3, SKBR3 and
e, while only a minor increase in red ﬂuorescence could be detected. Logarithmic scales
man Coulter Inc.). (C) Quantitative representation of JC1 (green to red) ratios obtained
ared to their respective controls. (D) Changes in the JC1 green ﬂuorescence (indicates
tial) were monitored upon Salinomycin treatment for 24 h and 48 h. PC3, SKBR3 and
cept MDAMB468 cells at 48 h that show a decrease in red ﬂuorescence but increased
24 h but JC1 ratio is regained to normal by 48 h. (F) Salinomycin decreases the expres-
signiﬁcant difference (P b 0.05). NS = nonsigniﬁcant.
80
100
60
40
20
0
200
150
100
0
50
250
200
150
100
50
0
100000
80000
60000
40000
20000
0
100
125
75
50
25
0
R
el
at
iv
e 
%
 J
C1
 ra
tio
Red Florescence
Green Florescence
D
E
F
M
ea
n 
Fl
or
es
ce
nc
e
M
ea
n 
Fl
or
es
ce
nc
e
M
ea
n 
Fl
or
es
ce
nc
e
M
ea
n 
Fl
or
es
ce
nc
e
Fig. 4 (continued).
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shown at the upper panel. JC1 signal quantiﬁcation by ﬂow cytometry
(Fig. 4C, D) to analyze changes in mitochondrial function shows that
there is an increase in both JC1 green and red ﬂuorescence in breast can-
cer cell lines (SKBR3 and MDAMB468) at 24 h and 48 h with the excep-
tion that MDAMB468 cells show decreased red ﬂuorescence at 48 h but
increased green ﬂuorescence (Fig. 4D). Prostate cancer PC3 cell lines
show a strong increase in green ﬂuorescence but no statistically signiﬁ-
cant changes in red ﬂuorescence. Thus, Salinomycin treated cancer
cells, when analyzed as a whole, show drastic increase in JC1 (green/
red) ratio (Fig. 4C) indicating a net increase in depolarizedmitochondria.
However, Fig. 4B clearly shows the appearance of subpopulation of can-
cer cells with a strong red signal (hyperpolarized mitochondria), upon
Salinomycin treatment. In ﬁbroblasts, JC1 red ﬂuorescence does not
change signiﬁcantly under Salinomycin treatment at 24 h and 48 h,
however green ﬂuorescence shows a very signiﬁcant decrease at 24 h
and a partial decrease at 48 h thus causing a decrease in JC1 ratio initially
with the signs of JC1 ratio recovery to normalcy by 48 h (Fig. 4E). The
observed changes in mitochondria by confocal ﬂuorescence microscopy
correspond in decreased expression of MFN2 and increased expres-
sion of DRP1 upon Salinomycin treatment, as shown by Western
blot (Fig. 4F).
Similar results were obtained using MitoTracker Green FM and
MitoTracker Red CMXRos dyes that indicate similar parameters as
that of JC1 green and JC1 red ﬂuorescence respectively. As shown inSupplementary Fig. 4, MitoTracker Red andMitoTracker Green signals
increased in Salinomycin treated cells compared to the control cells.
Consistent to the JC1 ratio data MitoTracker Green ﬂuorescence in-
creased more drastically compared to MitoTracker Red, thus further
supporting a marked increase in mitochondrial mass combined with
a signiﬁcant, net decrease in mitochondrial polarity.
To gain further insight into the functional state of mitochondria, we
measured ATP-levels in primary cells and cancer cells treated with
Salinomycin. A steady decrease in the amount of ATP levels was ob-
served in both prostate cancer PC3 cell line and breast cancer SKBR3
and MDAMB468 cells (Fig. 5) treated with 10 μM Salinomycin for 12,
24, 36 and 48 h. However, there was no such alteration observed in
human normal dermal ﬁbroblasts (Fig. 5).
3.4. Salinomycin disrupts mitochondrial network and induces mitophagy
Salinomycin treated cells showed various mitochondrial abnor-
malities and mitoptotic changes (Fig. 6A, and Supplementary Fig.
6A) [34]. Furthermore, EM-micrographs indicate that mitochondria
(in addition to previously reported ER role in this capacity) may be
the sources of membranes for the formation of autophagosomes, as
a conspicuous number of mitochondria like structures showed encap-
sulated darkly stained lysosomal-like bodies (Supplementary Fig. 6B)
[35]. Electron micrographs also showed relatively shorter mitochon-
dria in the Salinomycin treated cells (Fig. 6A), as compared to the
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Fig. 5. Salinomycin treatment of cancer cells triggers decrease in ATP content: total ATP levels were measured in human normal dermal ﬁbroblasts and cancer cells, upon treatment
with 10 μM Salinomycin. ATP-level was not changed in human normal dermal ﬁbroblasts upon Salinomycin treatment, however the same Salinomycin treatment causes a strong,
time-dependent ATP-depletion in cancer cell lines. *Represents statistically signiﬁcant difference (P b 0.05).
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A manual count of total mitochondria per cell using electron micro-
graphs also showed a decrease in the number of mitochondria with
intact morphological features (Fig. 5B). In accordance with the elec-
tron microscopy data, a careful analysis of confocal images obtained
for treated and non-treated cancer cells stained with MitoTracker
Red CMXRos indicates mitochondria with intact mitochondrial poten-
tial. Furthermore, we observe a lower number of mitochondria with
increased size (Fig. 5C, D, and Supplementary Fig. 7) that may be in-
dicative for mitochondrial swelling.
Mitochondrial autophagy was further conﬁrmed by LC3 signal
colocalization with the mitochondria (MitoTracker Red) in both primary
and cancer cells treatedwith 10 μMSalinomycin (Fig. 6E). In the sameﬁg-
ure, Salinomycin treated cells show disruption in the mitochondrial net-
work and relatively shorter mitochondria in ﬁbroblasts and swollen or
clumped mitochondria in cancer cell lines (Fig. 6E, and Supplementary
Fig. 8).
3.5. Salinomycin-induced cell death form, depends on drug's concentration
As indicated by MTT assay results (Fig. 7A), Salinomycin induced a
higher level of cell death in cancer cells as compared to human normal
dermal ﬁbroblasts (control). Since MTT assay does not distinguish be-
tween forms of cell death (it is a cell survival assay) we have next
probed cell death induced by Salinomycin, using ﬂow-cytometric
7AAD/Po-Pro assay that allows distinguishing between necrosis and
apoptosis. As shown in Fig. 7B, cancer cells treated with lower concen-
tration of Salinomycin (1 μM) show an increased number of early apo-
ptotic cells (increase in only Po-Pro staining) and dead cells/necrotic
cells (positive for Po-Pro and 7AAD stains). However, at higher concen-
tration of Salinomycin (10 μM), along with apoptotic population, a sig-
niﬁcant number of cells show increased 7AAD staining without
Po-Pro staining indicating a direct induction of necrotic cell death
(Fig. 7B). Salinomycin-induced necrosis was further conﬁrmed by
detecting HMGB1 in cell medium (HMGB1 normally resides in cell
nucleus, if found in cell medium, it is considered a necrotic marker).
Treatment of cancer cells with Salinomycin, increased medium contentof HMGB1 in a dose-dependentmanner (Fig. 7C). Unlike in cancer cells,
nomarked increase in cell deathwas observed in humannormal dermal
ﬁbroblasts treated with 10 μM Salinomycin (Fig. 7D).
3.6. Salinomycin triggers caspase mediated apoptosis among the cells
showing hyperpolarized mitochondria
Wehave previously shown (Fig. 4B) that a subset of cancer cells treat-
ed with Salinomycin responds with mitochondrial hyperpolarization,
rather than depolarization. Thus, we next checked the effects of
Salinomycin on caspase-3 activity in our cell linemodels,while costaining
them with MitoView 633 (indicator for polarized mitochondria).
Flow-cytometric data indicate a signiﬁcant increase in number of cells
with increased mitochondrial polarization upon treatment with 1 μM
Salinomycin for 24 h in SKBR3 and MDAMB468 cells (Fig. 8AB).
Surprisingly, we have observed a signiﬁcant increase in caspase-3 activity
predominantly in cells showing hyperpolarizedmitochondria (MitoView
633-high) in Salinomycin treated cells compared to their controls
(Fig. 8B). Similarly, Salinomycin treated cells showed an increase in
caspase-9 and caspase-8 activities compared to the controls (Fig. 8B).
Furthermore inhibition of caspase activity using a pan-caspase inhibitor
quinoline-Val-Asp(Ome)-CH2-O-phenoxy (Q-VD-OPh, 10 μM) showed
partial rescue from cell death by Salinomycin among SKBR3 cells
(Fig. 8C).
4. Discussion
Improving understanding of the biology of cancer, aswell as new ex-
perimental drugs, like Salinomycin, that preferentially target cancer
stem cells brings us closer to ﬁnding cure against this devastating
group of diseases. Cancer biology is complicated and each type of cancer
harbors its individual changes that may further evolve, once clinical
therapy progresses. Still, some core aspects of cancer biology are preva-
lent in different forms of cancer. Among them are: (i) the presence of
cancer stem cells (CSC) (tumor initiating cells) in (almost) every cancer,
and (ii), set of metabolic changes, and anomalies in mitochondrial biol-
ogy (Warburg effect), that make cancer metabolism largely dependent
Fig. 6. Salinomycin induces alteration in mitochondrial tubular network and triggers mitophagy: (A) TEM pictures showing Salinomycin induced mitochondrial fragmentation.
(B) Salinomycin decreases the number of functional mitochondria in treated cancer cells. (C) Representative images of ImageJ analysis by setting a threshold and quantifying the
MitoTracker Red stained cancer cells, (D) which also shows a decrease in mitochondrial count but with increase in mitochondrial size (possible swelling). (E) Mitochondrial autophagy:
colocalization of LC3 signal with mitochondria (MitoTracker Red) shown in the confocal images. *Represents statistically signiﬁcant difference (P b 0.05).
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the mechanism of Salinomycin toxicity, which as mentioned earlier [1],
preferentially kills cancer stem cells. We observed that Salinomycin
triggered an increase in autophagy (as shown with the increased LC3
ﬂux, number of lysosomes and formation of autophagolysosomes) in
both, cancer cell lines (prostate and breast cancer cells) and primary
cells (human normal dermal ﬁbroblasts). The autophagy induced by
Salinomycin was much stronger than by Rapamycin, which is typically
used as a “positive control” for autophagy experiments. Salinomycin
induced autophagy acts as a cell protective mechanism in cancer cells
as ablation of autophagywith either autophagic inhibitors (Chloroquine)
or experiments involving Salinomycin treatment of murine ﬁbroblasts
deﬁcient in ATG5 (ATG5−/−) showed increased cell death. Interestingly,the increase of Salinomycin's toxicity upon autophagy inhibition was
observed in breast and prostate cancer cells, but not in human normal
dermal ﬁbroblasts. This observation once again supports the popular
understanding that autophagy is primarily a cell survival pathway, but
if excessive, it may kill the cells [37].
The molecular mechanism of Salinomycin's toxicity is complex and
involves several effects. The increasing evidence of restoration to normal
mitochondrial function and subsequentmitigation to promote oxidative
phosphorylation as ameans tomeet cellular energy needs among cancer
cells is considered an adequate move to overhaul their apoptotic resis-
tance. In line to the role of mitochondria at the center of Salinomycin
induced cell death we have observed several abnormal mitochondrial
phenotypes andmitochondrial speciﬁc localization of autophagymarker
Fig. 7. Salinomycin induces both apoptosis and necrotic-like cell death: (A) MTT assay shows an increase in cell death in cells treated Salinomycin for 24 h and 48 h (please note
relative resistance of human normal dermal ﬁbroblasts to Salinomycin). (B) At low concentrations (1 μM) Salinomycin induces apoptosis (cells showing increase in Po-Pro staining)
and dead cells. (B) At a high concentration, Salinomycin triggers 2 different forms of cell death: for Po-Pro positive (apoptotic), and necrotic with increased staining for 7-AAD only;
a third population of cells (positive for both Po-Pro and 7-AAD) represent dead cells that are either late necrotic, or may have entered secondary necrosis. (C) Western blotting of
supernatants of the SKBR3 cells treated with 1 μM and 10 μM Salinomycin shows increased release of necrotic marker HMGB1 among cells treated with 10 μM Salinomycin com-
pared to both control and 1 μM Salinomycin treated cells. (D) Human normal dermal ﬁbroblasts treated with 10 μM Salinomycin for 48 h show no marked increase in staining for
apoptotic or necrotic markers. Logarithmic scales were used to display both parameters. Compensation was not applied (no emission spectra overlap).
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disintegration alongwith fragmentation, the result of mitochondrial dy-
namics of ﬁssion and fusion, upon Salinomycin treatment. Both ﬁssion
and fusion assist cellular stress rescue with mitochondrial fusion restor-
ing the minimally damaged mitochondria and ﬁssion resulting in the
cleavage of mitochondria followed by degradation of the damaged
mitochondrial portion [16]. Similarly, Salinomycin treatment to cancer
cells showed decreased number ofmitochondriawith intact innermem-
brane potential, increased staining for MitoTracker Red, a marker forintact inner mitochondrial membrane potential (ΔΨ) along with
increased mitochondrial mass (marked by increased JC1 green ﬂuores-
cence and MitoTracker Green FM). Moreover, there is no change in
PGC1α protein expression, a major regulator for nuclear initiated mito-
chondrial biogenesis, upon treatment with Salinomycin in cancer cell
lines (Supplementary Fig. 9); thus, inferring thatmitochondrial dynamic
fusion andﬁssionmechanisms contribute to the alterations inmitochon-
drial mass and maintenance of mitochondrial function in Salinomycin
treated cells. While we interpret the increase of JC1 green ﬂuorescence
Fig. 8. Salinomycin triggers caspase activity among cells with hyperpolarized mitochondria: (A) Flow cytometric analysis for caspase-3 activity and mitochondrial polarization
(MitoView 633) shows an increase in caspase-3 along with hyperpolarization in cancer cells treated with 1 μM Salinomycin for 24 h. Staurosporine (positive control) treatment
of cancer cells also showed similar hyperpolarization of mitochondria along with caspase-3 activity. (B) Quantiﬁcation of ﬂow cytometric data shows increase in activities of
caspase-3, -8, and -9 along with mitochondrial polarization in Salinomycin treated cells. (C) Inhibition of caspase activity using pan-caspase inhibitor Q-VD-OPh (10 μM) partially
counteracted Salinomycin induced cell death. *Represents statistically signiﬁcant difference (P b 0.05).
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cannot fully exclude the possibility that the signal increase by both stain-
ing procedures is due to mitochondrial swelling.
Salinomycin treated cancer cells showed a decreased number of mi-
tochondriawith intact ΔΨ and increased staining for mitochondrial po-
larity in a subpopulation of cancer cells. We have also observed an
increase in mitochondrial mass along with co-localization of LC3 with
the mitochondria and TEM images showing various abnormal mito-
chondrial phenotypes. The dysfunctional mitochondria are either elim-
inated bymitophagy or contributed the membrane to autophagosomes
to further encapsulate lysosomes and form autophago-lysosomes. This
is an important pro-survivalmechanism, since dysfunctional mitochon-
dria may actually consume ATP, and/or generate excessive amounts ofharmful reactive oxygen species, thus contributing to loss of cellular ho-
meostasis [38].
Similar to the hyperpolarization of mitochondria by Salinomycin in
cancer cells, early studies using mitochondria isolated from rat liver
Mitani et al., showed that Salinomycin increases release of K+ ions
from themitochondria opposing the valinomycin induced depolarization
of mitochondria by the uptake of K+ ions [39]. In the same study Mitani
et al., show that Salinomycinmediated inhibition of oxidative phosphor-
ylation is K+ ion dependent [39]. Likewise, in our current study cancer
cells treated with Salinomycin showed depletion in total cellular ATP in
a time and concentration dependent manner. ATP-depletion itself may
be a strong autophagy-inducing stimulus, as the cell tries to restore its
ATP-level [40,41].
2068 J.R. Jangamreddy et al. / Biochimica et Biophysica Acta 1833 (2013) 2057–2069Mitochondrial hyperpolarizationwas also reported in staurosporine-,
Fas- and p53-triggered apoptosis [25,27,28,42,43]. However, human
normal dermal ﬁbroblasts did not show such depletion in ATP upon
treatment with Salinomycin. The observed cancer cell speciﬁc deleteri-
ous effect of Salinomycin is explained by the fact that cancer cells harbor
various abnormalities within mitochondria, such as hyperpolarized mi-
tochondria along with defective mitochondrial ﬁssion and fusion mech-
anismsdue to the lack of functionally intactmitofusin proteins, DRP1 and
other proteins involved in the mitochondrial dynamics [22,44]. This
compromised mitochondrial function among cancer cells could be the
major contributor for the susceptibility of cancer cells to the ionic ﬂuctu-
ations induced by Salinomycin. Moreover, Dichloroacetate (DCA), which
is also a K+ ion channel modulator, and a molecule that preferentially
targets cancer cells, contrasting to Salinomycin induces depolarization
of mitochondria [44,45]. Thus, ionic manipulation within mitochondria
offers a unique target for the development of novel cancer therapies.
Similar to staurosporine, Salinomycin also triggered activation of ex-
ecutioner caspase-3 along with initiator caspase-9, but only among the
cells with hyperpolarized mitochondria. Inhibition of caspases using
pan-caspase inhibitor Q-VD-OPh partially protected from cell death in-
duced by Salinomycin but it was unable to fully reverse Salinomycin's
toxic effect. Besides the activation of apoptotic signaling pathways, we
also observed necrotic/necroptotic cell death, especially among cancer
cells treated with higher concentrations (10 μM) of Salinomycin. A sub-
population of cells showed increased staining with 7-AAD, which in the
used method preferentially stains necrotic cells, without any staining
with an apoptotic marker (Po-Pro). Necrosis/necroptosis induction was
also conﬁrmed by the detection of HMGB1 protein (necrotic marker)
[46,47] in the extracellular supernatant of cells treated with higher con-
centrations of Salinomycin.
Numerous manuscripts published within the recent decade, clearly
show that a number of cell death stimuli simultaneously activate apo-
ptosis, necrosis (or necroptosis) and autophagy [8]. Apoptosis however,
as the most specialized form of cell death usually prevails, not only due
to its speed, but also because caspases actively cleave and eliminate
elements of necrotic or autophagic machinery [15]. For example,
caspases cleave and inactivate key elements of autophagic machin-
ery, Beclin1, ATG4 and ATG5 [10,29,48]. Generated in the process
fragments, i.e. the C-terminal Beclin1 fragment gains the ability to am-
plify mitochondrion-dependent apoptosis despite a lack of a BH3
domain [49]. Furthermore, Bcl2 anti-apoptotic proteins (Bcl2/Bcl-XL)
can attach to Beclin1 and inhibit autophagy. Concomitantly, caspase-8
may block necrosis or necroptosis by the cleavage of RIPK1 and RIPK3,
and thus, prevent the formation of a necrosome [50].
In conclusion, this study shows that: (i) Salinomycin induces autoph-
agy that initially has a protective effect in cancer cells, (ii) Salinomycin
triggers mitochondrial swelling, mitophagy and disrupts mitochondrial
architecture, (iii) cancer cell speciﬁc toxicity of Salinomycin is throughmi-
tochondrial hyperpolarization observed preferentially in cancer cells, (iv)
Salinomycin induces both, caspase mediated apoptosis and necrosis/
necroptosis as evident by the release of HMGB1, and (v) Salinomycin
caused strong and time-dependent ATP-depletion in cancer cells, but
not in human normal dermal ﬁbroblasts. Thus, speciﬁc and more robust
toxicity of Salinomycin towards cancer and cancer stem cells without
much adversity towards normal cells warrants the use of Salinomycin
as an effective chemotherapeutic agent, in combination with autophagy
inhibitors.Acknowledgements
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